Successful co-treatment with LHRH-agonist for ovarian over-stimulation and cystic formation in premenopausal tamoxifen exposure

Author： Cohen I.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.55, Iss.2, 1999-05, pp. : 117-123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ovarian Overstimulation and Cystic Formation in Premenopausal Tamoxifen Exposure: Comparison between Tamoxifen-Treated and Nontreated Breast Cancer Patients

By Cohen I.   Figer A.   Tepper R.   Shapira J.   Altaras M.M.   Yigael D.   Beyth Y.  

Gynecologic Oncology, Vol. 72, Iss. 2, 1999-02 ,pp. : 202-207

Elsevier

Access to resources Recommend Favorite

Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrinedependent breast cancer: A report of two cases

By          

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1279-1282

Spandidos Publications

Access to resources Recommend Favorite

The Antiestrogen Tamoxifen in the Treatment of Recurrent Benign Cystic Mesothelioma

By Letterie G.S.   Yon J.L.  

Gynecologic Oncology, Vol. 70, Iss. 1, 1998-07 ,pp. : 131-133

Elsevier

Access to resources Recommend Favorite

Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: Results of the JMTO BC08-01 phase II trial

By                      

Oncology Reports, Vol. 29, Iss. 5, 2013-01 ,pp. : 1707-1713

Spandidos Publications

Access to resources Recommend Favorite

No Rules without Exception: Long-Term Complete Remission Observed in a Study Using a LH-RH Agonist in Platinum-Refractory Ovarian Cancer

By Paskeviciute L.   Roed H.   Engelholm S.A.  

Gynecologic Oncology, Vol. 86, Iss. 3, 2002-09 ,pp. : 297-301

Academic Press

Access to resources Recommend Favorite